Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)

NCT01423825 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: Sub C gp140 Vaccine
BIOLOGICAL: MF59C.1 Adjuvant
OTHER: Sodium chloride

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)